Healthcare provider profile · identity verified

Gerges E Makar, MBBCH

Internal Medicine · ANTHEM, AZ · NPI 1285955781

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	539	100
Atorvastatin Calcium	Atorvastatin Calcium	446	156
Gabapentin	Gabapentin	341	83
Lisinopril	Lisinopril	234	86
Quetiapine Fumarate	Quetiapine Fumarate	218	53
Furosemide	Furosemide	215	103
Tamsulosin Hcl	Tamsulosin Hcl	212	68
Amlodipine Besylate	Amlodipine Besylate	204	87
Eliquis	Apixaban	196	75
Metoprolol Succinate	Metoprolol Succinate	193	72
Metoprolol Tartrate	Metoprolol Tartrate	175	74
Pantoprazole Sodium	Pantoprazole Sodium	157	62
Potassium Chloride	Potassium Chloride	143	81
Clopidogrel	Clopidogrel Bisulfate	134	48
Losartan Potassium	Losartan Potassium	120	48
Levetiracetam	Levetiracetam	110	28
Metformin Hcl	Metformin Hcl	97	39
Mirtazapine	Mirtazapine	96	34
Donepezil Hcl	Donepezil Hcl	93	22
Memantine Hcl	Memantine Hcl	84	28
Escitalopram Oxalate	Escitalopram Oxalate	82	28
Carvedilol	Carvedilol	79	33
Jardiance	Empagliflozin	65	13
Trazodone Hcl	Trazodone Hcl	65	31
Amiodarone Hcl	Amiodarone Hcl	62	29
Famotidine	Famotidine	62	20
Duloxetine Hcl	Duloxetine Hcl	61	20
Omeprazole	Omeprazole	61	22
Enoxaparin Sodium	Enoxaparin Sodium	60	23
Simvastatin	Simvastatin	59	17
Warfarin Sodium	Warfarin Sodium	59	suppressed
Finasteride	Finasteride	56	18
Rosuvastatin Calcium	Rosuvastatin Calcium	55	21
Tramadol Hcl	Tramadol Hcl	54	20
Hydralazine Hcl	Hydralazine Hcl	53	25
Xifaxan	Rifaximin	50	suppressed
Divalproex Sodium	Divalproex Sodium	49	16
Sertraline Hcl	Sertraline Hcl	48	20
Spironolactone	Spironolactone	48	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	24
Latanoprost	Latanoprost	46	16
Midodrine Hcl	Midodrine Hcl	44	29
Allopurinol	Allopurinol	42	12
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	41	12
Hydroxyzine Hcl	Hydroxyzine Hcl	41	18
Lactulose	Lactulose	41	11
Calcitonin-Salmon	Calcitonin,salmon,synthetic	40	12
Entresto	Sacubitril/Valsartan	40	suppressed
Meloxicam	Meloxicam	37	11
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Topiramate	Topiramate	36	suppressed
Lorazepam	Lorazepam	35	14
Oxycodone Hcl	Oxycodone Hcl	35	16
Albuterol Sulfate Hfa	Albuterol Sulfate	34	26
Prednisone	Prednisone	34	17
Humalog	Insulin Lispro	33	suppressed
Cephalexin	Cephalexin	32	21
Ondansetron Hcl	Ondansetron Hcl	32	31
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	25
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	30	12
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	16
Methocarbamol	Methocarbamol	29	23
Bumetanide	Bumetanide	28	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Cefdinir	Cefdinir	27	22
Lantus	Insulin Glargine,hum.Rec.Anlog	27	11
Sucralfate	Sucralfate	27	14
Aripiprazole	Aripiprazole	26	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	26	suppressed
Hydrocortisone	Hydrocortisone	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Olanzapine	Olanzapine	25	suppressed
Baclofen	Baclofen	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	13
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	13
Scopolamine	Scopolamine	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	15
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	21	suppressed
Fentanyl	Fentanyl	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	13
Lacosamide	Lacosamide	20	suppressed
Risperidone	Risperidone	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Montelukast Sodium	Montelukast Sodium	19	12
Atenolol	Atenolol	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	12
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Amantadine	Amantadine Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Erythromycin	Erythromycin Base	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Vancomycin Hcl	Vancomycin Hcl	16	suppressed
Diazepam	Diazepam	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Sodium Chloride	0.9 % Sodium Chloride	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Digoxin	Digoxin	13	suppressed
Glipizide	Glipizide	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Donepezil Hcl Odt	Donepezil Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Admelog Solostar	Insulin Lispro	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Insulin Aspart	Insulin Aspart	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error